Related references
Note: Only part of the references are listed.Low-Dose Fluvastatin Reverses the Hypoxic Pulmonary Adventitial Fibroblast Phenotype in Experimental Pulmonary Hypertension
Christopher M. Carlin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Matrix Stiffness-Induced Myofibroblast Differentiation Is Mediated by Intrinsic Mechanotransduction
Xiangwei Huang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study
S. Clockaerts et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Prostaglandin F2α facilitates collagen synthesis in cardiac fibroblasts via an F-prostanoid receptor/protein kinase C/Rho kinase pathway independent of transforming growth factor β1
Wen-yuan Ding et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Fasudil, a Rho-Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
Chunguo Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Quantification of Lung Fibrosis and Emphysema in Mice Using Automated Micro-Computed Tomography
Ellen De langhe et al.
PLOS ONE (2012)
Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells
Amir A. Zeki et al.
RESPIRATORY RESEARCH (2012)
Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy
Jun Wei et al.
AUTOIMMUNITY REVIEWS (2011)
Reactive oxygen species-dependent RhoA activation mediates collagen synthesis in hyperoxic lung fibrosis
Dmitry Kondrikov et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis
Erol Aktunc et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2011)
Simvastatin induces apoptosis by a Rho-dependent mechanism in cultured cardiac fibroblasts and myofibroblasts
Miguel Copaja et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Idiopathic Pulmonary Fibrosis Is Associated With Endothelial To Mesenchymal Transition
Dilip Nataraj et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Endothelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis
Naozumi Hashimoto et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndrome
Kayoko Sato et al.
ATHEROSCLEROSIS (2010)
Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis
M. Jinnin et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Innovative therapies for systemic sclerosis
Voon H. Ong et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis
Philipp Eller et al.
KIDNEY INTERNATIONAL (2010)
Targeted therapy for systemic sclerosis: how close are we?
Manuel Ramos-Casals et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse
Amelie Servettaz et al.
JOURNAL OF IMMUNOLOGY (2009)
Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis
Masataka Kuwana et al.
MODERN RHEUMATOLOGY (2009)
Src kinases in systemic sclerosis
Catherine Skhirtladze et al.
ARTHRITIS AND RHEUMATISM (2008)
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
Alfiya Akhmetshina et al.
FASEB JOURNAL (2008)
Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts
Christopher M. Carlin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Elisabeth M. Zeisberg et al.
NATURE MEDICINE (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
Kevin K. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis
Masataka Kuwana et al.
ARTHRITIS AND RHEUMATISM (2006)
Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin
N Louneva et al.
ARTHRITIS AND RHEUMATISM (2006)
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts
YJ Li et al.
RESPIRATORY RESEARCH (2006)
Inhibitory effect of statins on renal epithelia-to-mesenchymal transition
Sharmila Patel et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol
JK Liao
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-ß1 -: Potential role in idiopathic pulmonary fibrosis
BC Willis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis
O Distler et al.
CIRCULATION RESEARCH (2004)
Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis
WH Ni et al.
CIRCULATION RESEARCH (2001)
Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)
M Eberlein et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Regulation of connective tissue growth factor (ccn2*; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins)
M Goppelt-Struebe et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Share Paper
